Inventor · disambiguated record
Vassiliki Boussiotis
Also filed as: BOUSSIOTIS VASSILIKI · BOUSSIOTIS VASSILIKI A
9 granted patents·5 pending applications·561 citations·filing 1994–2022
91Inventor score
Top patents by PatentIndex Score
14 records- 0197US7635757B2B7-4 Antibodies and uses thereforDANA FARBER CANCER INST INC·Filed 2006·Granted Dec 22, 2009·267 cites·13 claims
- 0297US6936704B1Nucleic acids encoding costimulatory molecule B7-4DANA FARBER CANCER INST INC·Filed 2000·Granted Aug 30, 2005·121 cites·64 claims
- 0396US7038013B2B7-4 polypeptides and uses thereforDANA FABER CANCER INST INC·Filed 2001·Granted May 2, 2006·88 cites·14 claims
- 0489US7700102B2Nucleic acids encoding CD100 moleculesDANA FARBER CANCER INST INC·Filed 2002·Granted Apr 20, 2010·23 cites·6 claims
- 0580US6576754B2CD100 antigen and uses thereforDANA FARBER CANCER INST INC·Filed 1995·Granted Jun 10, 2003·31 cites·4 claims
- 0673US11492403B2Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereofDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 8, 2022·1 cites·20 claims
- 0771US6451305B1Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligandDANA FARBER CANCER INST INC·Filed 1995·Granted Sep 17, 2002·23 cites·12 claims
- 0868US12258409B2Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodiesDANA FARBER CANCER INST INC·Filed 2022·Granted Mar 25, 2025·0 cites·18 claims
- 0958US2004037808A1Methods for modulating T cell responses by manipulating a commom cytokine receptor gamma-chainDANA FARBER CANCER INST INC·Filed 2003·Application pending·0 cites
- 1054US2002182727A1Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cellsDANA FARBER CANCER INST INC·Filed 2002·Application pending·0 cites
- 1154US2006233795A1Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cellsDANA FARBER CANCER INST INC·Filed 2006·Application pending·0 cites
- 1253US2002051784A1Methods for modulating T cell unresponsivenessDANA FARBER CANCER INST INC·Filed 2001·Application pending·0 cites
- 1352US6576236B1Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chainDANA FARBER CANCER INST INC·Filed 1994·Granted Jun 10, 2003·7 cites·11 claims
- 1449US2002127201A1Methods for inhibiting T cell responses by manipulating a common cytokine receptor gamma-chainDANA FARBER CANCER INST INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vassiliki Boussiotis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →